Medication-induced Hyperpigmentation

Medication-Induced Hyperpigmentation is a clinical dermatological condition characterized by abnormal cutaneous pigmentation resulting from the photochemical interaction of specific pharmacological agents with ultraviolet radiation.

177

Publications

5.1K

Citations

521

Authors

212

Institutions

Publications per year

2017–2026

22

Authors

521

  1. PR
    Philip R Cohen

    University of California San Diego, United States

    3 publications · 62 citations

    4

    h-index

  2. HT
    Hensin Tsao

    Massachusetts General Hospital, United States

    2 publications · 78 citations

    2

    h-index

  3. SM
    S. Meehan

    New York University, United States

    2 publications · 39 citations

    2

    h-index

  4. HE
    H. E. Lehmann

    McGill University, Canada

    2 publications · 45 citations

    2

    h-index

  5. TG
    Timothy G. Berger

    University of California, San Francisco, United States

    2 publications · 133 citations

    2

    h-index

1–5 of 521

Venues

  1. PubMed

    Repository · 27 publications · 644 citations

    17

    h-index

  2. Archives of Dermatology

    14 publications · 399 citations

    12

    h-index

  3. Journal of the American Academy of Dermatology

    JAAD · 10 publications · 491 citations

    10

    h-index

  4. Dermatology Online Journal

    9 publications · 167 citations

    9

    h-index

  5. Journal of Cutaneous Pathology

    JCP · 6 publications · 348 citations

    6

    h-index

1–5